47045-COG-C-UNDP-1 The Global Fund to Fight AIDS, Tuberculosis and Malaria <narrative>Project to improve the national response to HIV in the areas of prevention, care and support and to strengthen the response to tuberculosis in Congo  - Congo (01-Jan-2021-31-Dec-2023)</narrative> Congo, TB/HIV, United Nations Development Programme Goals: Réduire de 50% les nouvelles infections parmi les populations vulnérables (en l’occurrence les jeunes filles, les jeunes femmes), les populations clés et éliminer celles chez les enfants d'ici à 2023/Reduce new infections by 50% among vulnerable populations (young girls, young women), key populations and elimination among children by 2023; Réaliser les objectifs 90-90-90 en vue de réduire de manière significative la morbidité et la mortalité chez les PVVIH d'au moins 62% d'ici à 2023/Achieve the 90-90-90 targets to significantly reduce morbidity and mortality among PLHIV by at least 62% by 2023; Réduire le nombre de décès lié à la tuberculose de 35% à l'horizon 2023 par rapport à l'année 2015/Reduce the number of tuberculosis-related deaths by 35% by 2023 compared to 2015; Réduire l'incidence de la tuberculose de 20% à l'horizon 2023 par rapport à 2015/Reduce the incidence of tuberculosis by 20% by 2023 compared to 2015. Objectives: Renforcer les systèmes de surveillance en santé; Renforcer le système de laboratoire et la capacité de diagnostic; Renforcer les ressources huamaines de la santé y compris les agents de santé communautaire et la prévention et le contrôle des infections; Renforcer le système de gestion des produits de santé et les déchets; Accroître de 20% d'ici 2023 la notification de nouveaux cas et rechutes de tuberculose toutes formes par rapport à 2015/Increase to 20% by 2023 the notification of new and relapses cases of all forms of tuberculosis compared to 2015; Atteindre 70% de taux de sucès thérapeutique chez les nouveaux cas et rechutes de tuberculose toutes formes d'ici 2023/Achieve 70% treatment success rate in new and relapses cases of all forms of tuberculosis by 2023; Atteindre 80% de taux de succès thérapeutique chez les malades multi-résistants mis sous traitement de 2ème ligne d'ici 2023/Achieve 80% treatement success rate inMDR-TB patients on second line treatment by 2023. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme United Nations Development Programme The Global Fund to Fight AIDS, Tuberculosis and Malaria The Global Fund to Fight AIDS, Tuberculosis and Malaria Communications +41 58 791 1700 website@theglobalfund.org https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland The Global Fund to Fight AIDS, Tuberculosis and Malaria Grant Management Division xxxx xxxx Fund Portfolio Manager +41 58 791 1700 xxxx https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland Congo HIV Multicomponent, RSSH Tuberculosis Ensure healthy lives and promote well-being for all at all ages End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases Achieve universal health coverage HIV -> Differentiated HIV Testing Services -> Community-based testing HIV -> Differentiated HIV Testing Services -> Facility-based testing HIV -> Differentiated HIV Testing Services -> Self-testing HIV -> PMTCT -> Prong 2: Preventing unintended pregnancies among women living with HIV HIV -> PMTCT -> Prong 3: Preventing vertical HIV transmission HIV -> PMTCT -> Prong 4: Treatment, care and support to mothers living with HIV, their children and families HIV -> Prevention -> Behavior change interventions HIV -> Prevention -> Community empowerment HIV -> Prevention -> Condom and lubricant programming HIV -> Prevention -> Prevention and management of co-infections and co-morbidities (Prevention) HIV -> Prevention -> Sexual and reproductive health services, including STIs HIV -> Reducing human rights-related barriers to HIV/TB services -> HIV and HIV/TB-related legal services HIV -> Reducing human rights-related barriers to HIV/TB services -> Human rights and medical ethics related to HIV and HIV/TB for health care providers HIV -> Reducing human rights-related barriers to HIV/TB services -> Reducing HIV-related gender discrimination, harmful gender norms and violence against women and girls in all their diversity HIV -> Reducing human rights-related barriers to HIV/TB services -> Sensitization of law-makers and law-enforcement agents HIV -> Reducing human rights-related barriers to HIV/TB services -> Stigma and discrimination reduction (HIV/TB) HIV -> Treatment, care and support -> Differentiated ART service delivery and HIV care HIV -> Treatment, care and support -> Prevention and management of co-infections and co-morbidities (Treatment, care and support) HIV -> Treatment, care and support -> Treatment monitoring - Viral load Multicomponent -> Program management -> Coordination and management of national disease control programs Multicomponent -> Program management -> Grant management RSSH -> RSSH: Health management information systems and M&E -> Analysis, evaluations, reviews and transparency RSSH -> RSSH: Health management information systems and M&E -> Program and data quality RSSH -> RSSH: Health management information systems and M&E -> Routine reporting RSSH -> RSSH: Health management information systems and M&E -> Surveys RSSH -> RSSH: Health products management systems -> Avoidance, reduction and management of health care waste RSSH -> RSSH: Health products management systems -> Policy, strategy, governance RSSH -> RSSH: Health products management systems -> Storage and distribution capacity RSSH -> RSSH: Laboratory systems -> Information systems and integrated specimen transport networks RSSH -> RSSH: Laboratory systems -> Infrastructure and equipment management systems RSSH -> RSSH: Laboratory systems -> Laboratory supply chain systems RSSH -> RSSH: Laboratory systems -> National laboratory governance and management structures RSSH -> RSSH: Laboratory systems -> Quality management systems and accreditation Tuberculosis -> MDR-TB -> Case detection and diagnosis (MDR-TB) Tuberculosis -> MDR-TB -> Engaging all care providers (MDR-TB) Tuberculosis -> MDR-TB -> Treatment (MDR-TB) Tuberculosis -> TB care and prevention -> Case detection and diagnosis (TB care and prevention) Tuberculosis -> TB care and prevention -> Community TB care delivery Tuberculosis -> TB care and prevention -> Engaging all care providers (TB care and prevention) Tuberculosis -> TB care and prevention -> Key populations (TB care and prevention) - Mobile populations: refugees, migrants and internally displaced people Tuberculosis -> TB care and prevention -> Key populations (TB care and prevention) - Prisoners Tuberculosis -> TB care and prevention -> Prevention (TB care and prevention) Tuberculosis -> TB care and prevention -> Treatment (TB care and prevention) Tuberculosis -> TB/HIV -> Collaborative activities with other programs and sectors (TB/HIV) Tuberculosis -> TB/HIV -> Engaging all care providers (TB/HIV) Tuberculosis -> TB/HIV -> TB/HIV - Collaborative interventions 10021547.59 11608214.90 17884783.90 5297420.77 3813237.47 19245261.91 Global Fund commitment to COG-C-UNDPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 8330120.45 Global Fund disbursement to COG-C-UNDPP01 (Multilateral). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 4982976.89 Global Fund disbursement to COG-C-UNDPP01 (Multilateral). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 47650.69 Global Fund commitment to COG-C-UNDPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 24597.42 Global Fund disbursement to COG-C-UNDPP01 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 5932164.56 Global Fund disbursement to COG-C-UNDPP01 (Multilateral). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 4211225.43 Global Fund commitment to COG-C-UNDPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 2895139.25 Global Fund disbursement to COG-C-UNDPP01 (Multilateral). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 25809.30 Global Fund disbursement to COG-C-UNDPP01 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 25809.30 Global Fund commitment to COG-C-UNDPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme -23053.27 Global Fund commitment to COG-C-UNDPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme -2756.02 Global Fund commitment to COG-C-UNDPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 0.00 Global Fund commitment to COG-C-UNDPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme -1316086.19 Global Fund commitment to COG-C-UNDPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 12258853.87 Global Fund commitment to COG-C-UNDPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 5919922.26 Global Fund disbursement to COG-C-UNDPP01 (Multilateral). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 1057166.39 Global Fund disbursement to COG-C-UNDPP01 (Multilateral). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 24740.80 Global Fund commitment to COG-C-UNDPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 3859511.39 Global Fund disbursement to COG-C-UNDPP01 (Multilateral). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 1227311.53 Global Fund disbursement to COG-C-UNDPP01 (Multilateral). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 3625506.09 Global Fund commitment to COG-C-UNDPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme -194942.29 Global Fund commitment to COG-C-UNDPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 2062568.21 Global Fund disbursement to COG-C-UNDPP01 (Multilateral). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 1562937.88 Global Fund disbursement to COG-C-UNDPP01 (Multilateral). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme -608.01 Global Fund commitment to COG-C-UNDPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 25348.81 Global Fund commitment to COG-C-UNDPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme -24740.80 Global Fund commitment to COG-C-UNDPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme -25348.81 Global Fund commitment to COG-C-UNDPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 3479741.91 Global Fund commitment to COG-C-UNDPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 1296789.28 Global Fund disbursement to COG-C-UNDPP01 (Multilateral). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme -13658.37 Global Fund commitment to COG-C-UNDPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 13658.37 Funds returned to the Global Fund from COG-C-UNDPP01 (Other 3rd Party). United Nations Development Programme The Global Fund to Fight AIDS, Tuberculosis and Malaria 6788180.67 Global Fund commitment to COG-C-UNDPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme -2182952.63 Global Fund commitment to COG-C-UNDPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 1822166.04 Global Fund disbursement to COG-C-UNDPP01 (Multilateral). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme -1301218.77 Global Fund commitment to COG-C-UNDPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 1301218.77 Funds returned to the Global Fund from COG-C-UNDPP01 (Other 3rd Party). United Nations Development Programme The Global Fund to Fight AIDS, Tuberculosis and Malaria 3860365.08 Global Fund disbursement to COG-C-UNDPP01 (Multilateral). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 166135.77 Global Fund disbursement to COG-C-UNDPP01 (Multilateral). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 5383751.15 Expenditure reported by United Nations Development Programme for COG-C-UNDPP01, Jan 2021 to Dec 2021. United Nations Development Programme 9932376.60 Expenditure reported by United Nations Development Programme for COG-C-UNDPP01, Jan 2022 to Dec 2022. United Nations Development Programme 15451612.52 Expenditure reported by United Nations Development Programme for COG-C-UNDPP01, Jan 2023 to Dec 2023. United Nations Development Programme 3126095.09 Expenditure reported by United Nations Development Programme for COG-C-UNDPP01, Jan 2024 to Jun 2024. United Nations Development Programme 5705594.73 Expenditure reported by United Nations Development Programme for COG-C-UNDPP01, Jul 2024 to Dec 2024. United Nations Development Programme 2340817.84 Expenditure reported by United Nations Development Programme for COG-C-UNDPP01, Jan 2025 to Jun 2025. United Nations Development Programme 4292574.95 Expenditure reported by United Nations Development Programme for COG-C-UNDPP01, Jan 2025 to Dec 2025. United Nations Development Programme <narrative>Grant page on the data explorer of the Global Fund.</narrative> An overview of a grant over its lifetime. <narrative>Grant terms and conditions.</narrative> General terms and conditions which apply to Global Fund grants. <narrative>2020 - Funding Request - Window 3 - TB/HIV - Congo - English</narrative> Funding Request of funding request FR883-COG-C-01. <narrative>2020 - Funding Request - Window 3 - TB/HIV - Congo - Français</narrative> Funding Request of funding request FR883-COG-C-01. <narrative>Percentage of men who have sex with men that have received an HIV test during the reporting period and know their results</narrative> Module: Differentiated HIV Testing Services. <narrative>Percentage of men who have sex with men that have received an HIV test during the reporting period and know their results</narrative> Geographic coverage: Subnational, 100% of national program target. Aggregation: Non cumulative. Numerator: 56; Denominator: 296. Numerator: 704; Denominator: 859. Numerator: 230; Denominator: 859. Numerator: 1408; Denominator: 1718. Numerator: 1240; Denominator: 1718. Numerator: 704; Denominator: 859. Numerator: 1010; Denominator: 859. Numerator: 785.4; Denominator: 924. Numerator: 841; Denominator: 924. Numerator: 1570.8; Denominator: 1848. Numerator: 1718; Denominator: 1848. Numerator: 785.4; Denominator: 924. Numerator: 877; Denominator: 924. <narrative>Percentage of sex workers that have received an HIV test during the reporting period and know their results</narrative> Module: Differentiated HIV Testing Services. <narrative>Percentage of sex workers that have received an HIV test during the reporting period and know their results</narrative> Geographic coverage: Subnational, 100% of national program target. Aggregation: Non cumulative. Numerator: 876; Denominator: 7228. Numerator: 1565.2; Denominator: 2408. Numerator: 674; Denominator: 1204. Numerator: 782.6; Denominator: 1204. Numerator: 0; Denominator: 0. Numerator: 782.6; Denominator: 1204. Numerator: 674; Denominator: 1204. Numerator: 2837; Denominator: 4047. Numerator: 1175; Denominator: 4047. Numerator: 5674; Denominator: 8094. Numerator: 3765; Denominator: 8094. Numerator: 2837; Denominator: 4047. Numerator: 2590; Denominator: 4047. Numerator: 3350.25; Denominator: 4467. Numerator: 2792; Denominator: 4467. Numerator: 6700.6; Denominator: 8934. Numerator: 6152; Denominator: 8934. Numerator: 3350.25; Denominator: 4467. Numerator: 3360; Denominator: 4467. <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative> Module: MDR-TB. <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative> Module: MDR-TB. <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. <narrative>Percentage of HIV-positive women who received ART during pregnancy and/or labour and delivery</narrative> Module: PMTCT. <narrative>Percentage of HIV-positive women who received ART during pregnancy and/or labour and delivery</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - special. Numerator: 504; Denominator: 4891. Numerator: 502; Denominator: 5015. Numerator: 83; Denominator: 5015. Numerator: 1254; Denominator: 5015. Numerator: 726; Denominator: 5015. Numerator: 752; Denominator: 5015. Numerator: 643; Denominator: 5015. Numerator: 924; Denominator: 5129. Numerator: 422; Denominator: 5129. Numerator: 2052; Denominator: 5129. Numerator: 990; Denominator: 5129. Numerator: 1128; Denominator: 5129. Numerator: 568; Denominator: 5129. Numerator: 1386; Denominator: 5251. Numerator: 585; Denominator: 5251. Numerator: 2888; Denominator: 5251. Numerator: 1263; Denominator: 5251. Numerator: 1502; Denominator: 5251. Numerator: 678; Denominator: 5251. <narrative>Percentage of men who have sex with men reached with HIV prevention programs</narrative> Module: Prevention. <narrative>Percentage of men who have sex with men reached with HIV prevention programs</narrative> Geographic coverage: Subnational, 100% of national program target. Aggregation: Non cumulative. Numerator: 954; Denominator: 1157. Numerator: 250; Denominator: 1157. Numerator: 1908; Denominator: 2314. Numerator: 1542; Denominator: 2314. Numerator: 954; Denominator: 1157. Numerator: 1292; Denominator: 1157. Numerator: 2054; Denominator: 2404. Numerator: 2203; Denominator: 2404. Numerator: 1027; Denominator: 1202. Numerator: 1035; Denominator: 1202. Numerator: 1027; Denominator: 1202. Numerator: 1168; Denominator: 1202. <narrative>Percentage of sex workers reached with HIV prevention programs</narrative> Module: Prevention. <narrative>Percentage of sex workers reached with HIV prevention programs</narrative> Geographic coverage: Subnational, 100% of national program target. Aggregation: Non cumulative. Numerator: 2676; Denominator: 4116. Numerator: 716; Denominator: 2058. Numerator: 1338; Denominator: 2058. Numerator: 0; Denominator: 0. Numerator: 1338; Denominator: 2058. Numerator: 716; Denominator: 2058. Numerator: 8994; Denominator: 12849. Numerator: 3581; Denominator: 12850. Numerator: 4497; Denominator: 6424.5. Numerator: 1173; Denominator: 6425. Numerator: 4497; Denominator: 6424.5. Numerator: 2408; Denominator: 6425. Numerator: 9926; Denominator: 13235. Numerator: 8273; Denominator: 13236. Numerator: 4963; Denominator: 6617.5. Numerator: 3306; Denominator: 6618. Numerator: 4963; Denominator: 6617.5. Numerator: 4967; Denominator: 6618. <narrative>Completeness of facility reporting: Percentage of expected facility monthly reports (for the reporting period) that are actually received</narrative> Module: RSSH: Health management information systems and M&E. <narrative>Completeness of facility reporting: Percentage of expected facility monthly reports (for the reporting period) that are actually received</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. Numerator: 394; Denominator: 438. Numerator: 807; Denominator: 846. Numerator: 788; Denominator: 876. Numerator: 1553; Denominator: 1692. Numerator: 394; Denominator: 438. Numerator: 746; Denominator: 846. Numerator: 557; Denominator: 746. Numerator: 189; Denominator: 746. Numerator: 438; Denominator: 438. Numerator: 737; Denominator: 846. Numerator: 738; Denominator: 618. Numerator: 180; Denominator: 228. Numerator: 876; Denominator: 876. Numerator: 1571; Denominator: 1728. Numerator: 438; Denominator: 438. Numerator: 834; Denominator: 882. Numerator: 876; Denominator: 876. Numerator: 4610; Denominator: 6378. Numerator: 438; Denominator: 438. Numerator: 2233; Denominator: 3144. Numerator: 2035; Denominator: 2808. Numerator: 198; Denominator: 336. Numerator: 438; Denominator: 438. Numerator: 2377; Denominator: 3234. <narrative>Timeliness of facility reporting: Percentage of submitted facility monthly reports (for the reporting period) that are received on time per the national guidelines</narrative> Module: RSSH: Health management information systems and M&E. <narrative>Timeliness of facility reporting: Percentage of submitted facility monthly reports (for the reporting period) that are received on time per the national guidelines</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. Numerator: 788; Denominator: 876. Numerator: 505; Denominator: 1692. Numerator: 394; Denominator: 438. Numerator: 261; Denominator: 846. Numerator: 394; Denominator: 438. Numerator: 244; Denominator: 846. Numerator: 70; Denominator: 244. Numerator: 174; Denominator: 244. Numerator: 438; Denominator: 438. Numerator: 285; Denominator: 846. Numerator: 120; Denominator: 618. Numerator: 165; Denominator: 228. Numerator: 876; Denominator: 876. Numerator: 909; Denominator: 1680. Numerator: 438; Denominator: 438. Numerator: 624; Denominator: 834. Numerator: 438; Denominator: 438. Numerator: 1971; Denominator: 2233. Numerator: 1783; Denominator: 2035. Numerator: 188; Denominator: 198. Numerator: 876; Denominator: 876. Numerator: 4832; Denominator: 5467. Numerator: 438; Denominator: 438. Numerator: 2861; Denominator: 3234. <narrative>Percentage of health facilities providing diagnostic services with tracer items available on the day of the visit or day of reporting</narrative> Module: RSSH: Health products management systems. <narrative>Percentage of health facilities providing diagnostic services with tracer items available on the day of the visit or day of reporting</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - other. Numerator: 94; Denominator: 134. Numerator: 31; Denominator: 134. Numerator: 94; Denominator: 134. Numerator: 134; Denominator: 134. Numerator: 94; Denominator: 134. Numerator: 31; Denominator: 134. Numerator: 107; Denominator: 134. Numerator: 248; Denominator: 248. Numerator: 107; Denominator: 134. Numerator: 126; Denominator: 134. Numerator: 107; Denominator: 134. Numerator: 248; Denominator: 248. Numerator: 120.6; Denominator: 134. Numerator: 215; Denominator: 218. Numerator: 120.6; Denominator: 134. Numerator: 248; Denominator: 248. Numerator: 120.6; Denominator: 134. Numerator: 215; Denominator: 218. <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative> Module: TB care and prevention. <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. Numerator: 11802. Numerator: 10834. Numerator: 10834. Numerator: 968. Numerator: 968. Numerator: 4387. Numerator: 4387. Numerator: 4387. Numerator: 4387. Numerator: 6767. Numerator: 6767. Numerator: 6767. Numerator: 5035. Numerator: 5035. Numerator: 5035. Numerator: 663. Numerator: 663. Numerator: 663. Numerator: 0. Numerator: 0. Numerator: 0. Numerator: 0. Numerator: 646. Numerator: 646. Numerator: 646. Numerator: 13766. Numerator: 11979. Numerator: 5506. Numerator: 6140. Numerator: 8260. Numerator: 5839. Numerator: 2517. Numerator: 2435. Numerator: 3404. Numerator: 1283. Numerator: 4096. Numerator: 460. Numerator: 6504. Numerator: 6673. Numerator: 14454. Numerator: 13511. Numerator: 7950. Numerator: 6838. Numerator: 6305. Numerator: 533. Numerator: 2951. Numerator: 2960. Numerator: 3878. Numerator: 3404. Numerator: 3031. Numerator: 403. Numerator: 7285. Numerator: 7097. Numerator: 3500; Denominator: 7097; Percentage: 49.32%. Numerator: 1574; Denominator: 7097; Percentage: 22.18%. Numerator: 15177. Numerator: 14370. Numerator: 7892. Numerator: 7273. Numerator: 7155; Denominator: 7273; Percentage: 98.38%. Numerator: 118; Denominator: 7273; Percentage: 1.62%. Numerator: 3934; Denominator: 7273; Percentage: 54.09%. Numerator: 3125; Denominator: 7273; Percentage: 42.97%. Numerator: 4148; Denominator: 7273; Percentage: 57.03%. Numerator: 5447; Denominator: 7273; Percentage: 74.89%. Numerator: 1215; Denominator: 7273; Percentage: 16.71%. Numerator: 611; Denominator: 7273; Percentage: 8.4%. <narrative>Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative> Module: TB care and prevention. <narrative>Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. Numerator: 6690; Denominator: 10791. Numerator: 8408; Denominator: 11161. Numerator: 4045; Denominator: 5599. Numerator: 4363; Denominator: 5562. Numerator: 9338; Denominator: 11979. Numerator: 4756; Denominator: 6140. Numerator: 4582; Denominator: 5839. Numerator: 10879; Denominator: 13511. Numerator: 5083; Denominator: 6673. Numerator: 5796; Denominator: 6838. <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative> Module: TB/HIV. <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. Numerator: 621; Denominator: 966. Numerator: 258; Denominator: 506. Numerator: 363; Denominator: 460. Numerator: 697; Denominator: 1006. Numerator: 384; Denominator: 603. Numerator: 313; Denominator: 403. Numerator: 557; Denominator: 687. Numerator: 1168; Denominator: 1379. Numerator: 611; Denominator: 692. <narrative>Percentage of registered new and relapse TB patients with documented HIV status</narrative> Module: TB/HIV. <narrative>Percentage of registered new and relapse TB patients with documented HIV status</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. Numerator: 5088; Denominator: 11979. Numerator: 3345; Denominator: 6140. Numerator: 1743; Denominator: 5839. Numerator: 3795; Denominator: 6673. Numerator: 7602; Denominator: 13511. Numerator: 3807; Denominator: 6838. Numerator: 5523; Denominator: 7097. Numerator: 11581; Denominator: 14370. Numerator: 6058; Denominator: 7273. <narrative>Percentage of people on ART among all people living with HIV at the end of the reporting period</narrative> Module: Treatment, care and support. <narrative>Percentage of people on ART among all people living with HIV at the end of the reporting period</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - other. Numerator: 26030; Denominator: 103863; Percentage: 25%. Numerator: 24624; Denominator: 95866; Percentage: 25.69%. Numerator: 24624; Denominator: 95866; Percentage: 25.69%. Numerator: 24624; Denominator: 95866; Percentage: 25.69%. Numerator: 24624; Denominator: 95866; Percentage: 25.69%. Numerator: 1406; Denominator: 7997; Percentage: 17.58%. Numerator: 1406; Denominator: 7997; Percentage: 17.58%. Numerator: 1406; Denominator: 7997; Percentage: 17.58%. Numerator: 1406; Denominator: 7997; Percentage: 17.58%. Numerator: 17484; Denominator: 69302; Percentage: 25.23%. Numerator: 17484; Denominator: 69302; Percentage: 25.23%. Numerator: 17484; Denominator: 69302; Percentage: 25.23%. Numerator: 17484; Denominator: 69302; Percentage: 25.23%. Numerator: 17484; Denominator: 69302; Percentage: 25.23%. Numerator: 17484; Denominator: 65376; Percentage: 26.74%. Numerator: 17484; Denominator: 65376; Percentage: 26.74%. Numerator: 17484; Denominator: 65376; Percentage: 26.74%. Numerator: 17484; Denominator: 65376; Percentage: 26.74%. Numerator: 17484; Denominator: 65376; Percentage: 26.74%. Numerator: 409; Denominator: 3359; Percentage: 12.18%. Numerator: 409; Denominator: 3359; Percentage: 12.18%. Numerator: 409; Denominator: 3359; Percentage: 12.18%. Numerator: 409; Denominator: 3359; Percentage: 12.18%. Numerator: 1507; Denominator: 10952; Percentage: 13.76%. Numerator: 1507; Denominator: 10952; Percentage: 13.76%. Numerator: 1507; Denominator: 10952; Percentage: 13.76%. Numerator: 1507; Denominator: 10952; Percentage: 13.76%. Numerator: 1098; Denominator: 7593; Percentage: 14.46%. Numerator: 1098; Denominator: 7593; Percentage: 14.46%. Numerator: 1098; Denominator: 7593; Percentage: 14.46%. Numerator: 1098; Denominator: 7593; Percentage: 14.46%. Numerator: 7140; Denominator: 34559; Percentage: 20.66%. Numerator: 7140; Denominator: 34559; Percentage: 20.66%. Numerator: 7140; Denominator: 34559; Percentage: 20.66%. Numerator: 7140; Denominator: 34559; Percentage: 20.66%. Numerator: 7140; Denominator: 30492; Percentage: 23.42%. Numerator: 7140; Denominator: 30492; Percentage: 23.42%. Numerator: 7140; Denominator: 30492; Percentage: 23.42%. Numerator: 7140; Denominator: 30492; Percentage: 23.42%. Numerator: 7140; Denominator: 30492; Percentage: 23.42%. Numerator: 258; Denominator: 1010; Percentage: 25.54%. Numerator: 258; Denominator: 1010; Percentage: 25.54%. Numerator: 258; Denominator: 1010; Percentage: 25.54%. Numerator: 258; Denominator: 1010; Percentage: 25.54%. Numerator: 685; Denominator: 3006; Percentage: 22.79%. Numerator: 685; Denominator: 3006; Percentage: 22.79%. Numerator: 685; Denominator: 3006; Percentage: 22.79%. Numerator: 685; Denominator: 3006; Percentage: 22.79%. Numerator: 427; Denominator: 1996; Percentage: 21.39%. Numerator: 427; Denominator: 1996; Percentage: 21.39%. Numerator: 427; Denominator: 1996; Percentage: 21.39%. Numerator: 427; Denominator: 1996; Percentage: 21.39%. Numerator: 34866; Denominator: 109347; Percentage: 32%. Numerator: 29487; Denominator: 109347; Percentage: 27%. Numerator: 31925; Denominator: 109347; Percentage: 29%. Numerator: 27567; Denominator: 109347; Percentage: 25.2%. Numerator: 34866; Denominator: 109347; Percentage: 32%. Numerator: 29487; Denominator: 109347; Percentage: 27%. Numerator: 28055. Numerator: 1432. Numerator: 19184. Numerator: 18438. Numerator: 435. Numerator: 1659. Numerator: 1224. Numerator: 10303. Numerator: 9617. Numerator: 275. Numerator: 738. Numerator: 463. Numerator: 37163; Denominator: 112602; Percentage: 33%. Numerator: 32003; Denominator: 112602; Percentage: 28.4%. Numerator: 30470. Numerator: 1533. Numerator: 20586. Numerator: 19807; Denominator: 70877; Percentage: 27.95%. Numerator: 505; Denominator: 3642; Percentage: 13.87%. Numerator: 1769; Denominator: 11873; Percentage: 14.9%. Numerator: 1264; Denominator: 8232; Percentage: 15.35%. Numerator: 11417. Numerator: 10663; Denominator: 33058; Percentage: 32.26%. Numerator: 365; Denominator: 1095; Percentage: 33.33%. Numerator: 875; Denominator: 3259; Percentage: 26.85%. Numerator: 510; Denominator: 2164; Percentage: 23.57%. Numerator: 40609; Denominator: 112602; Percentage: 36%. Numerator: 34061; Denominator: 112602; Percentage: 30.2%. Numerator: 40609; Denominator: 112602; Percentage: 36%. Numerator: 34061; Denominator: 112602; Percentage: 30.2%. Numerator: 23154. Numerator: 22339; Denominator: 70877; Percentage: 31.52%. Numerator: 10125; Denominator: 33058; Percentage: 30.63%. Numerator: 45976; Denominator: 116220; Percentage: 40%. Numerator: 38071; Denominator: 116220; Percentage: 32.8%. Numerator: 42756; Denominator: 116220; Percentage: 37%. Numerator: 36103; Denominator: 116220; Percentage: 31.1%. Numerator: 34169; Denominator: 36103; Percentage: 94.64%. Numerator: 1934; Denominator: 36103; Percentage: 5.36%. Numerator: 24390; Denominator: 36103; Percentage: 67.56%. Numerator: 23402; Denominator: 70877; Percentage: 33.02%. Numerator: 676; Denominator: 3642; Percentage: 18.56%. Numerator: 2261; Denominator: 11873; Percentage: 19.04%. Numerator: 1585; Denominator: 8232; Percentage: 19.25%. Numerator: 11713; Denominator: 36103; Percentage: 32.44%. Numerator: 10767; Denominator: 33058; Percentage: 32.57%. Numerator: 467; Denominator: 1095; Percentage: 42.65%. Numerator: 1170; Denominator: 3259; Percentage: 35.9%. Numerator: 704; Denominator: 2164; Percentage: 32.53%. Numerator: 45976; Denominator: 116220; Percentage: 40%. Numerator: 38071; Denominator: 116220; Percentage: 32.8%. Numerator: 36175; Denominator: 38071; Percentage: 95.02%. Numerator: 1896; Denominator: 38071; Percentage: 4.98%. Numerator: 25664; Denominator: 38071; Percentage: 67.41%. Numerator: 24727; Denominator: 36175; Percentage: 68.35%. Numerator: 681; Denominator: 1175; Percentage: 57.96%. Numerator: 2303; Denominator: 3505; Percentage: 65.71%. Numerator: 1622; Denominator: 2330; Percentage: 69.61%. Numerator: 12407; Denominator: 38071; Percentage: 32.59%. Numerator: 11448; Denominator: 36175; Percentage: 31.65%. Numerator: 494; Denominator: 1175; Percentage: 42.04%. Numerator: 1202; Denominator: 3505; Percentage: 34.29%. Numerator: 708; Denominator: 2330; Percentage: 30.39%. 47045-COG-C-UNDP-2 The Global Fund to Fight AIDS, Tuberculosis and Malaria <narrative>Project to continue improving the national response to HIV in the areas of prevention, care and support, and to strengthen the response to Tuberculosis in Congo - Congo (01-Jan-2024-31-Dec-2026)</narrative> Congo, TB/HIV, United Nations Development Programme Goals: VIH-But-1: Accélérer la réponse nationale et renforcer l’efficience et la performance des programmes en vue de mettre fin à l’épidémie du VIH en tant que menace de santé publique d’ici à fin 2030 / HIV-Goal-1: Accelerate the national response and strengthen program efficiency and performance to end the HIV epidemic as a public health threat by the end of 2030; TB-But-1: Réduire l’incidence de la tuberculose de 370 cas pour 100 000 habitants en 2021 à 353 cas pour 100 000 habitants en 2027 / TB-Goal-1: Reduce the incidence of TB from 370 cases per 100,000 population in 2021 to 353 cases per 100,000 population in 2027; TB-But-2 : Réduire le taux de mortalité lié à la tuberculose de 54 décès pour 100,000 habitants en 2021 à 42 décès pour 100 000 habitants en 2027. / TB-Goal-2: Reduce the TB mortality rate from 54 deaths per 100,000 population in 2021 to 42 deaths per 100,000 population in 2027; TB-But-3 : Renforcer la gouvernance du programme national de lutte contre la tuberculose. / TB-Goal-2: Reduce the TB mortality rate from 54 deaths per 100,000 population in 2021 to 42 deaths per 100,000 population in 2027. Objectives: Objectif-VIH-1: Les nouvelles infections à VIH sont réduites à moins 50% d'ici fin 2027./ Objective- VIH-1: New HIV infections are reduced to less than 50% by the end of 2027; Objectif-VIH-2: D’ici fin 2027, la mortalité liée au VIH/sida est réduite d'au moins 30% par rapport au niveau de 2022./ Objective-VIH-2: By the end of 2027, HIV/AIDS-related mortality is reduced by at least 30% compared to the 2022 level; Objectif-VIH-3: Les obstacles liés aux droits humains et aux inégalités de genre entravant l’accès des populations clés et vulnérables aux services de prévention, de dépistage et de prise en charge du VIH sont réduits./ Objective-VIH-3: Human rights and gender barriers to accessing HIV prevention, testing and care services for key and vulnerable populations are reduced; Objectif-VIH-4: Les systèmes de gestion, de suivi évaluation, de coordination et de gouvernance sensible au genre et inclusifs de la réponse au VIH sont renforcés et résilients durant la période 2023- 2027./ Objective-VIH-4: Gender-responsive and inclusive management, monitoring and evaluation, coordination and governance systems of the HIV response are strengthened and resilient during the period 2023-2027; TB-Objectif-1: Faire passer la couverture du traitement de 55% en 2021 à 90 % en / TB-Objective-1: Increase treatment coverage from 55% in 2021 to 90% in 2027; TB-Objectif-2 : Traiter 21 368 patients, d’ici à 2027 avec un succès de traitement au moins 90 %./ TB-Objective-2 :Treat 21,368 patients by 2027 with at least 90% treatment success; TB-Objectif-3 : Faire passer à 100 % d’ici à 2027, la couverture de l’enregistrement et de la notification fiables des données concernant la tuberculose. / TB-Objective-3 :Increase coverage of reliable TB data notification and reporting to 100% by 2027; TB-Objectif-4 : Atteindre 70% d’ici à 2027 la couverture de l’appui social apporté aux personnes atteintes de tuberculose pharmacosensible conformé bacteriologiquement remplissant les conditions requises et 100% des patients atteintes de tuberculose pharmacoresistante. / TB-Objective-4 :Achieve 70% coverage of social support for eligible drug-susceptible TB patients and 100% of drug-resistant TB patients by 2027. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme United Nations Development Programme The Global Fund to Fight AIDS, Tuberculosis and Malaria The Global Fund to Fight AIDS, Tuberculosis and Malaria Communications +41 58 791 1700 website@theglobalfund.org https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland The Global Fund to Fight AIDS, Tuberculosis and Malaria Grant Management Division xxxx xxxx Fund Portfolio Manager +41 58 791 1700 xxxx https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland Congo HIV Multicomponent, RSSH Tuberculosis Ensure healthy lives and promote well-being for all at all ages End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases Achieve universal health coverage HIV -> Differentiated HIV Testing Services -> Community-based testing for AGYW and their male sexual partners programs HIV -> Differentiated HIV Testing Services -> Community-based testing for KP programs HIV -> Differentiated HIV Testing Services -> Community-based testing outside of KP and AGYW programs HIV -> Differentiated HIV Testing Services -> Facility-based testing for adolescent girls and young women (AGYW) and their male sexual partners programs HIV -> Differentiated HIV Testing Services -> Facility-based testing for key population (KP) programs HIV -> Differentiated HIV Testing Services -> Facility-based testing outside of key population (KP) and adolescent girls and young women (AGYW) programs HIV -> Differentiated HIV Testing Services -> Self-testing for AGYW and their male sexual partners programs HIV -> Differentiated HIV Testing Services -> Self-testing for KP programs HIV -> Elimination of vertical transmission of HIV, syphilis and hepatitis B -> Early infant diagnosis and follow-up HIV testing for exposed infants HIV -> Elimination of vertical transmission of HIV, syphilis and hepatitis B -> Integrated testing of pregnant women for HIV, syphilis and hepatitis B HIV -> Elimination of vertical transmission of HIV, syphilis and hepatitis B -> Post-natal infant prophylaxis HIV -> Elimination of vertical transmission of HIV, syphilis and hepatitis B -> Prevention of incident HIV among pregnant and breastfeeding women HIV -> Prevention package for adolescent girls and young women (AGYW) and male sexual partners in high HIV incidence settings -> Comprehensive sexuality education for adolescent girls and young women (AGYW) and adolescent boys and young men (ABYM) HIV -> Prevention package for adolescent girls and young women (AGYW) and male sexual partners in high HIV incidence settings -> HIV prevention communication, information and demand creation for AGYW in high HIV incidence settings HIV -> Prevention package for adolescent girls and young women (AGYW) and male sexual partners in high HIV incidence settings -> Sexual and reproductive health services, including STIs, hepatitis, post-violence care for AGYW and male sexual partners in high HIV incidence settings HIV -> Prevention package for men who have sex with men (MSM) and their sexual partners -> Community empowerment for MSM HIV -> Prevention package for men who have sex with men (MSM) and their sexual partners -> Condom and lubricant programming for MSM HIV -> Prevention package for men who have sex with men (MSM) and their sexual partners -> HIV prevention communication, information and demand creation for MSM HIV -> Prevention package for men who have sex with men (MSM) and their sexual partners -> Pre-exposure prophylaxis (PrEP) programming for MSM HIV -> Prevention package for men who have sex with men (MSM) and their sexual partners -> Removing human rights-related barriers to prevention for MSM HIV -> Prevention package for men who have sex with men (MSM) and their sexual partners -> Sexual and reproductive health services, including STIs, hepatitis, post-violence care for MSM HIV -> Prevention package for sex workers, their clients and other sexual partners -> Community empowerment for sex workers HIV -> Prevention package for sex workers, their clients and other sexual partners -> Condom and lubricant programming for sex workers HIV -> Prevention package for sex workers, their clients and other sexual partners -> HIV prevention communication, information and demand creation for sex workers HIV -> Prevention package for sex workers, their clients and other sexual partners -> Pre-exposure prophylaxis (PrEP) programming for sex workers HIV -> Prevention package for sex workers, their clients and other sexual partners -> Removing human rights-related barriers to prevention for sex workers HIV -> Prevention package for sex workers, their clients and other sexual partners -> Sexual and reproductive health services, including STIs, hepatitis, post-violence care for sex workers HIV -> Reducing human rights-related barriers to HIV/TB services -> Eliminating stigma and discrimination in all settings HIV -> Reducing human rights-related barriers to HIV/TB services -> Ensuring nondiscriminatory provision of health care HIV -> Reducing human rights-related barriers to HIV/TB services -> Reducing HIV-related gender discrimination, harmful gender norms and violence against women and girls in all their diversity HIV -> Treatment, care and support -> Diagnosis and management of advanced HIV disease (adults and children) HIV -> Treatment, care and support -> HIV treatment and differentiated service delivery - adults (15 and above) HIV -> Treatment, care and support -> HIV treatment and differentiated service delivery - children (under 15) HIV -> Treatment, care and support -> Integrated management of common co-infections and co-morbidities (adults and children) HIV -> Treatment, care and support -> Treatment monitoring - Viral load and antiretroviral (ARV) toxicity Multicomponent -> Program management -> Coordination and management of national disease control programs Multicomponent -> Program management -> Grant management RSSH -> RSSH: Health products management systems -> Supply chain information systems RSSH -> RSSH: Monitoring and evaluation systems -> Data quality RSSH -> RSSH: Monitoring and evaluation systems -> Routine reporting Tuberculosis -> Collaboration with other providers and sectors -> Community-based TB/DR-TB care Tuberculosis -> Collaboration with other providers and sectors -> Private provider engagement in TB/DR-TB care Tuberculosis -> Drug-resistant (DR)-TB diagnosis, treatment and care -> DR-TB diagnosis/drug susceptibility testing (DST) Tuberculosis -> Drug-resistant (DR)-TB diagnosis, treatment and care -> DR-TB treatment, care and support Tuberculosis -> Key and vulnerable populations (KVP) - TB/DR-TB -> KVP - Children and adolescents Tuberculosis -> Key and vulnerable populations (KVP) - TB/DR-TB -> KVP - Mobile population (migrants/refugees/IDPs) Tuberculosis -> Key and vulnerable populations (KVP) - TB/DR-TB -> KVP - People in prisons/jails/detention centers Tuberculosis -> TB diagnosis, treatment and care -> TB screening and diagnosis Tuberculosis -> TB diagnosis, treatment and care -> TB treatment, care and support Tuberculosis -> TB/DR-TB Prevention -> Infection prevention and control (IPC) Tuberculosis -> TB/DR-TB Prevention -> Preventive treatment Tuberculosis -> TB/HIV -> TB/HIV - Collaborative interventions Tuberculosis -> TB/HIV -> TB/HIV - Prevention Tuberculosis -> TB/HIV -> TB/HIV - Screening, testing and diagnosis Tuberculosis -> TB/HIV -> TB/HIV - Treatment and care 8514505.12 9937773.79 13740162.77 13553968.40 Global Fund commitment to COG-C-UNDPP02. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 5001036.48 Global Fund disbursement to COG-C-UNDPP02 (Multilateral). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 3239965.23 Global Fund disbursement to COG-C-UNDPP02 (Multilateral). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 2949980.13 Global Fund disbursement to COG-C-UNDPP02 (Multilateral). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 2362986.56 Global Fund disbursement to COG-C-UNDPP02 (Multilateral). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 1172131.15 Global Fund commitment to COG-C-UNDPP02. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 1172131.15 Global Fund disbursement to COG-C-UNDPP02 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 11768392.77 Global Fund commitment to COG-C-UNDPP02. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 5049126.00 Global Fund disbursement to COG-C-UNDPP02 (Multilateral). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 6511678.25 Global Fund disbursement to COG-C-UNDPP02 (Multilateral). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme -207588.51 Global Fund commitment to COG-C-UNDPP02. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 5504112.92 Global Fund commitment to COG-C-UNDPP02. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 3278688.52 Global Fund disbursement to COG-C-UNDPP02 (Multilateral). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 8534693.88 Expenditure reported by United Nations Development Programme for COG-C-UNDPP02, Jan 2024 to Dec 2024. United Nations Development Programme 7956014.90 Expenditure reported by United Nations Development Programme for COG-C-UNDPP02, Jan 2025 to Dec 2025. United Nations Development Programme <narrative>Grant page on the data explorer of the Global Fund.</narrative> An overview of a grant over its lifetime. <narrative>Grant terms and conditions.</narrative> General terms and conditions which apply to Global Fund grants. <narrative>2023 - Funding Request - Window 1 - Multicomponent - Congo - English</narrative> Funding Request of funding request FR1560-COG-Z. <narrative>2023 - Funding Request - Window 1 - Multicomponent - Congo - Français</narrative> Funding Request of funding request FR1560-COG-Z. <narrative>Percentage of MSM that have received an HIV test during the reporting period in KP-specific programs and know their results</narrative> Module: Differentiated HIV Testing Services. <narrative>Percentage of MSM that have received an HIV test during the reporting period in KP-specific programs and know their results</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. Numerator: 1240; Denominator: 1718. Numerator: 1986; Denominator: 3546. Numerator: 3972; Denominator: 7092. Numerator: 4163; Denominator: 7092. Numerator: 1986; Denominator: 3546. Numerator: 2277; Denominator: 3546. Numerator: 5259; Denominator: 7304. Numerator: 5860; Denominator: 7304. Numerator: 2630; Denominator: 3652. Numerator: 2629; Denominator: 3652. Numerator: 2926; Denominator: 3652. Numerator: 2878; Denominator: 3762. Numerator: 2878; Denominator: 3762. <narrative>Percentage of at-risk AGYW that have received an HIV test during the reporting period in AGYW programs</narrative> Module: Differentiated HIV Testing Services. <narrative>Percentage of at-risk AGYW that have received an HIV test during the reporting period in AGYW programs</narrative> Geographic coverage: Subnational, 100% of national program target. Aggregation: Non cumulative. Numerator: 13390; Denominator: 603080. Numerator: 13393; Denominator: 105249. Numerator: 13943; Denominator: 312476.5. Numerator: 30675; Denominator: 624953. Numerator: 26331; Denominator: 624954. Numerator: 16732; Denominator: 312476.5. Numerator: 11482; Denominator: 312477. Numerator: 23457; Denominator: 321851. Numerator: 26808; Denominator: 321851. <narrative>Percentage of sex workers that have received an HIV test during the reporting period in KP-specific programs and know their results</narrative> Module: Differentiated HIV Testing Services. <narrative>Percentage of sex workers that have received an HIV test during the reporting period in KP-specific programs and know their results</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. Numerator: 3765; Denominator: 8094. Numerator: 5180; Denominator: 6771. Numerator: 10359; Denominator: 13542. Numerator: 11518; Denominator: 13542. Numerator: 5179; Denominator: 6771. Numerator: 5820; Denominator: 6771. Numerator: 11298; Denominator: 13948. Numerator: 12560; Denominator: 13948. Numerator: 5649; Denominator: 6974. Numerator: 5649; Denominator: 6974. Numerator: 6280; Denominator: 6974. Numerator: 6142; Denominator: 7183. Numerator: 6142; Denominator: 7183. <narrative>Number of people with confirmed RR-TB and/or MDR-TB notified</narrative> Module: Drug-resistant (DR)-TB diagnosis, treatment and care. <narrative>Number of people with confirmed RR-TB and/or MDR-TB notified</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. <narrative>Percentage of people with confirmed RR-TB and/or MDR-TB that began second-line treatment</narrative> Module: Drug-resistant (DR)-TB diagnosis, treatment and care. <narrative>Percentage of people with confirmed RR-TB and/or MDR-TB that began second-line treatment</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. Numerator: 216; Denominator: 216; Percentage: 100%. Numerator: 209. Numerator: 209. Numerator: 7. Numerator: 7. Numerator: 79. Numerator: 79. Numerator: 15. Numerator: 15. Numerator: 137. Numerator: 137. Numerator: 216. Numerator: 216. Percentage: 100%. Percentage: 100%. Numerator: 238; Denominator: 241; Percentage: 98.76%. Percentage: 100%. Numerator: 121; Denominator: 121; Percentage: 100%. Percentage: 100%. Percentage: 100%. Numerator: 196; Denominator: 196; Percentage: 100%. Percentage: 100%. Numerator: 86; Denominator: 86; Percentage: 100%. Numerator: 0; Denominator: 0. Numerator: 0; Denominator: 0. Numerator: 0; Denominator: 0. Numerator: 0. Numerator: 0; Denominator: 0. Numerator: 0. Percentage: 100%. Percentage: 100%. <narrative>Treatment success rate of RR-TB and/or MDR-TB: Percentage of patients with RR and/or MDR-TB successfully treated</narrative> Module: Drug-resistant (DR)-TB diagnosis, treatment and care. <narrative>Treatment success rate of RR-TB and/or MDR-TB: Percentage of patients with RR and/or MDR-TB successfully treated</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. Numerator: 289; Denominator: 347. Numerator: 192; Denominator: 232. Numerator: 144; Denominator: 173. Numerator: 145; Denominator: 174. Numerator: 83; Denominator: 96. Numerator: 336; Denominator: 394. Numerator: 199; Denominator: 228. Numerator: 168; Denominator: 197. Numerator: 168; Denominator: 197. Numerator: 101; Denominator: 116. Numerator: 192; Denominator: 220. Numerator: 193; Denominator: 221. <narrative>Percentage of HIV-exposed infants receiving a virological test for HIV within 2 months of birth</narrative> Module: Elimination of vertical transmission of HIV, syphilis and hepatitis B. <narrative>Percentage of HIV-exposed infants receiving a virological test for HIV within 2 months of birth</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - special. Numerator: 314; Denominator: 7807; Percentage: 4.02%. Numerator: 318; Denominator: 8005; Percentage: 3.97%. Numerator: 16; Denominator: 8005; Percentage: 0.2%. Numerator: 9; Denominator: 8005; Percentage: 0.11%. Numerator: 1247; Denominator: 8326; Percentage: 15%. Numerator: 1208; Denominator: 6504; Percentage: 18.57%. Numerator: 623; Denominator: 8326; Percentage: 7.48%. Numerator: 624; Denominator: 8326; Percentage: 7.49%. Numerator: 672; Denominator: 6504; Percentage: 10.33%. Numerator: 1166. Numerator: 42. Numerator: 0. Numerator: 1814; Denominator: 8640; Percentage: 21%. Numerator: 860; Denominator: 6554; Percentage: 13.12%. Numerator: 907; Denominator: 8640; Percentage: 10.5%. Numerator: 907; Denominator: 8640; Percentage: 10.5%. Numerator: 486; Denominator: 6554; Percentage: 7.42%. Numerator: 1398; Denominator: 8964; Percentage: 15.6%. Numerator: 1397; Denominator: 8964; Percentage: 15.58%. <narrative>Percentage of pregnant women who know their HIV status</narrative> Module: Elimination of vertical transmission of HIV, syphilis and hepatitis B. <narrative>Percentage of pregnant women who know their HIV status</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - special. Numerator: 48349; Denominator: 247616; Percentage: 19.53%. Numerator: 51495; Denominator: 247621; Percentage: 20.8%. Numerator: 51495; Denominator: 247621; Percentage: 20.8%. Numerator: 1032; Denominator: 247621; Percentage: 0.42%. Numerator: 1032; Denominator: 247621; Percentage: 0.42%. Numerator: 0; Denominator: 247621; Percentage: 0%. Numerator: 0; Denominator: 247621; Percentage: 0%. Numerator: 97725; Denominator: 259036; Percentage: 37.7%. Numerator: 104807; Denominator: 236736; Percentage: 44.27%. Numerator: 48862; Denominator: 259036; Percentage: 18.86%. Numerator: 48863; Denominator: 259036; Percentage: 18.86%. Numerator: 53862; Denominator: 236736; Percentage: 22.75%. Numerator: 102667. Numerator: 1967. Numerator: 0. Numerator: 59159; Denominator: 264768; Percentage: 22.34%. Numerator: 118318; Denominator: 264768; Percentage: 44.7%. Numerator: 121368; Denominator: 244070; Percentage: 49.73%. Numerator: 59159; Denominator: 264768; Percentage: 22.34%. Numerator: 55854; Denominator: 244070; Percentage: 22.88%. Numerator: 118483. Numerator: 2885. Numerator: 0. Percentage: 26.38%. Percentage: 26.38%. <narrative>Percentage of at-risk adolescent girls and young women reached with HIV prevention programs</narrative> Module: Prevention package for adolescent girls and young women (AGYW) and male sexual partners in high HIV incidence settings. <narrative>Percentage of at-risk adolescent girls and young women reached with HIV prevention programs</narrative> Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative. Numerator: 29483; Denominator: 208458. Numerator: 45123; Denominator: 301986.5. Numerator: 90246; Denominator: 603973. Numerator: 90246; Denominator: 603974. Numerator: 45123; Denominator: 301986.5. Numerator: 60126; Denominator: 301987. Numerator: 55772; Denominator: 312476.5. Numerator: 111544; Denominator: 624953. Numerator: 111542; Denominator: 624954. Numerator: 55772; Denominator: 312476.5. Numerator: 55772; Denominator: 312477. Numerator: 67020; Denominator: 321851. Numerator: 67020; Denominator: 321851. <narrative>Percentage of men who have sex with men reached with HIV prevention programs</narrative> Module: Prevention package for men who have sex with men (MSM) and their sexual partners. <narrative>Percentage of men who have sex with men reached with HIV prevention programs</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. Numerator: 1542; Denominator: 2314. Numerator: 2482; Denominator: 3546. Numerator: 4964; Denominator: 7092. Numerator: 4982; Denominator: 7092. Numerator: 2482; Denominator: 3546. Numerator: 2500; Denominator: 3546. Numerator: 5844; Denominator: 7304. Numerator: 5880; Denominator: 7304. Numerator: 2922; Denominator: 3652. Numerator: 2922; Denominator: 3652. Numerator: 2940; Denominator: 3652. Numerator: 3198; Denominator: 3762. Numerator: 3198; Denominator: 3762. <narrative>Percentage of sex workers reached with HIV prevention programs</narrative> Module: Prevention package for sex workers, their clients and other sexual partners. <narrative>Percentage of sex workers reached with HIV prevention programs</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. Numerator: 3581; Denominator: 12849. Numerator: 11510; Denominator: 13542. Numerator: 11526; Denominator: 13542. Numerator: 5755; Denominator: 6771. Numerator: 5755; Denominator: 6771. Numerator: 5820; Denominator: 6771. Numerator: 6277; Denominator: 6974. Numerator: 12554; Denominator: 13948. Numerator: 12560; Denominator: 13948. Numerator: 6277; Denominator: 6974. Numerator: 6280; Denominator: 6974. Numerator: 6824; Denominator: 7183. Numerator: 6824; Denominator: 7183. <narrative>Number of patients with of all forms of TB notified (i.e., bacteriologically confirmed + clinically diagnosed); *includes only those with new and relapse TB</narrative> Module: TB diagnosis, treatment and care. <narrative>Number of patients with of all forms of TB notified (i.e., bacteriologically confirmed + clinically diagnosed); *includes only those with new and relapse TB</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. <narrative>Percentage of new and relapse TB patients tested using WHO recommended rapid diagnostic tests at the time of diagnosis</narrative> Module: TB diagnosis, treatment and care. <narrative>Percentage of new and relapse TB patients tested using WHO recommended rapid diagnostic tests at the time of diagnosis</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. Numerator: 3840; Denominator: 13511. Numerator: 7180; Denominator: 13226. Numerator: 3369; Denominator: 6085. Numerator: 7327; Denominator: 14368. Numerator: 3964; Denominator: 7194. <narrative>Treatment success rate- all forms: Percentage of patients with all forms of TB, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB patients notified during a specified period; *includes only those with new and relapse TB</narrative> Module: TB diagnosis, treatment and care. <narrative>Treatment success rate- all forms: Percentage of patients with all forms of TB, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB patients notified during a specified period; *includes only those with new and relapse TB</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. Numerator: 9315; Denominator: 11979; Percentage: 77.76%. Numerator: 444; Denominator: 966; Percentage: 45.96%. Numerator: 444; Denominator: 966; Percentage: 45.96%. Percentage: 85%. Numerator: 12439; Denominator: 14454; Percentage: 86.06%. Percentage: 85%. Percentage: 85%. Numerator: 6297; Denominator: 7273; Percentage: 86.58%. Percentage: 90%. Numerator: 11376; Denominator: 13336; Percentage: 85.3%. Percentage: 90%. Percentage: 90%. Numerator: 5172; Denominator: 6085; Percentage: 85%. Numerator: 0; Denominator: 0. Percentage: 95%. Percentage: 95%. <narrative>Number of people in contact with TB patients who began preventive therapy</narrative> Module: TB/DR-TB Prevention. <narrative>Number of people in contact with TB patients who began preventive therapy</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative> Module: TB/HIV. <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. Numerator: 697; Denominator: 1006; Percentage: 69.28%. Numerator: 968. Numerator: 968. Numerator: 29. Numerator: 29. Numerator: 9. Numerator: 9. Numerator: 570. Numerator: 570. Numerator: 436. Numerator: 436. Numerator: 2647; Denominator: 3529; Percentage: 75%. Numerator: 1405; Denominator: 1619; Percentage: 86.78%. Numerator: 1313; Denominator: 1754; Percentage: 75%. Numerator: 1334; Denominator: 1775; Percentage: 75.15%. Numerator: 605; Denominator: 687; Percentage: 88.06%. Numerator: 1633; Denominator: 2045; Percentage: 79.85%. Numerator: 3296; Denominator: 4120; Percentage: 80%. Numerator: 1504; Denominator: 1628; Percentage: 92.38%. Numerator: 1663; Denominator: 2075; Percentage: 80.14%. Numerator: 801; Denominator: 890; Percentage: 90%. Numerator: 0; Denominator: 1504; Percentage: 0%. Numerator: 0; Denominator: 0. Numerator: 0; Denominator: 0. Numerator: 0; Denominator: 0. Numerator: 0; Denominator: 0. Numerator: 2001; Denominator: 2358; Percentage: 84.86%. Numerator: 2042; Denominator: 2398; Percentage: 85.15%. <narrative>Percentage of people living with HIV currently enrolled on antiretroviral therapy who started TB preventive treatment (TPT) during the reporting period</narrative> Module: TB/HIV. <narrative>Percentage of people living with HIV currently enrolled on antiretroviral therapy who started TB preventive treatment (TPT) during the reporting period</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - special. Numerator: 2140; Denominator: 15704. Numerator: 14863; Denominator: 49468. Numerator: 14730; Denominator: 44049. Numerator: 14863; Denominator: 49468. Numerator: 14730; Denominator: 44049. Numerator: 8490; Denominator: 64479. Numerator: 9709; Denominator: 48982. Numerator: 8490; Denominator: 64479. Numerator: 9709; Denominator: 48982. Numerator: 10518; Denominator: 85272. <narrative>Percentage of registered new and relapse TB patients with documented HIV status</narrative> Module: TB/HIV. <narrative>Percentage of registered new and relapse TB patients with documented HIV status</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. Numerator: 7602; Denominator: 13511; Percentage: 56.27%. Numerator: 1006. Numerator: 1006. Numerator: 11762; Denominator: 16803; Percentage: 70%. Numerator: 11146; Denominator: 13226; Percentage: 84.27%. Numerator: 5846; Denominator: 8351; Percentage: 70%. Numerator: 5916; Denominator: 8452; Percentage: 70%. Numerator: 5332; Denominator: 6085; Percentage: 87.63%. Numerator: 6809; Denominator: 9079; Percentage: 75%. Numerator: 6809; Denominator: 9079; Percentage: 75%. Numerator: 11663; Denominator: 14368; Percentage: 81.17%. Percentage: 75%. Numerator: 5775; Denominator: 7194; Percentage: 80.28%. Numerator: 1628. Numerator: 7846; Denominator: 9807; Percentage: 80%. Numerator: 8007; Denominator: 10008; Percentage: 80.01%. <narrative>Percentage of adults (15 and above) on ART among all adults living with HIV at the end of the reporting period</narrative> Module: Treatment, care and support. <narrative>Percentage of adults (15 and above) on ART among all adults living with HIV at the end of the reporting period</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - other. Numerator: 32017; Denominator: 131659. Numerator: 222107; Denominator: 382636. Numerator: 222107; Denominator: 382636. Numerator: 268682; Denominator: 382636. Numerator: 268682; Denominator: 382636. Numerator: 45320; Denominator: 138056. Numerator: 46005; Denominator: 144453. Numerator: 42031; Denominator: 117584. Numerator: 46005; Denominator: 144453. Numerator: 42031; Denominator: 117584. Numerator: 28007; Denominator: 82309. Numerator: 14024; Denominator: 35275. Numerator: 60216; Denominator: 151786. Numerator: 46582; Denominator: 120585. Numerator: 54311; Denominator: 148120. Numerator: 60216; Denominator: 151786. Numerator: 46582; Denominator: 120585. Numerator: 31089; Denominator: 46582. Numerator: 15493; Denominator: 46582. Numerator: 70335; Denominator: 154232. Numerator: 78450; Denominator: 156678. <narrative>Percentage of children (under 15) on ART among all children living with HIV at the end of the reporting period</narrative> Module: Treatment, care and support. <narrative>Percentage of children (under 15) on ART among all children living with HIV at the end of the reporting period</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - other. Numerator: 7900; Denominator: 12415. Numerator: 12138; Denominator: 24192. Numerator: 12138; Denominator: 24192. Numerator: 7864; Denominator: 12138. Numerator: 7864; Denominator: 12138. Numerator: 3412; Denominator: 12717. Numerator: 3462; Denominator: 13020. Numerator: 2018; Denominator: 10141. Numerator: 3462; Denominator: 13020. Numerator: 2018; Denominator: 10141. Numerator: 971; Denominator: 10141. Numerator: 1047; Denominator: 10141. Numerator: 4533; Denominator: 13301. Numerator: 2400; Denominator: 10056. Numerator: 4087; Denominator: 13160. Numerator: 4533; Denominator: 13301. Numerator: 2400; Denominator: 10056. Numerator: 1197; Denominator: 2400. Numerator: 1203; Denominator: 2400. Numerator: 6117; Denominator: 13434. Numerator: 6650; Denominator: 13566. <narrative>Percentage of people on ART among all people living with HIV at the end of the reporting period</narrative> Module: Treatment, care and support. <narrative>Percentage of people on ART among all people living with HIV at the end of the reporting period</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - other. Numerator: 34061; Denominator: 144325. Numerator: 23154; Denominator: 144325. Numerator: 23154; Denominator: 144325. Numerator: 10907; Denominator: 144325. Numerator: 10907; Denominator: 144325. Numerator: 48732; Denominator: 156305. Numerator: 49468; Denominator: 156305. Numerator: 44049; Denominator: 127725. Numerator: 49468; Denominator: 156305. Numerator: 44049; Denominator: 127725. Numerator: 29041; Denominator: 127725. Numerator: 15008; Denominator: 127725. Numerator: 64749; Denominator: 164458. Numerator: 48982; Denominator: 130641. Numerator: 58399; Denominator: 164458. Numerator: 64749; Denominator: 164458. Numerator: 48982; Denominator: 130641. Numerator: 32286; Denominator: 48559. Numerator: 16696; Denominator: 48559. Numerator: 76452; Denominator: 171780. Numerator: 85272; Denominator: 171780. <narrative>Percentage of pregnant women living with HIV who received antiretroviral medicine to reduce the risk of vertical transmission of HIV</narrative> Module: Treatment, care and support. <narrative>Percentage of pregnant women living with HIV who received antiretroviral medicine to reduce the risk of vertical transmission of HIV</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - special. Numerator: 1677; Denominator: 7807. Numerator: 1713; Denominator: 8326. Numerator: 3427; Denominator: 8326. Numerator: 2590; Denominator: 6504. Numerator: 1714; Denominator: 8326. Numerator: 1016; Denominator: 6504. Numerator: 4005; Denominator: 8640. Numerator: 1783; Denominator: 6554. Numerator: 2002; Denominator: 8640. Numerator: 2003; Denominator: 8640. Numerator: 789; Denominator: 6554. Numerator: 2286; Denominator: 8964. Numerator: 2286; Denominator: 8964.